Which of the following is NOT a cause of acalculous cholecystitis?
True about hydatid cyst of liver?
A 36-year-old woman has become increasingly icteric for 1 month. She has had several bouts of colicky, midabdominal pain for 3 years. On physical examination, she has generalized jaundice with scleral icterus. Her BMI is 32. There is tenderness in the right upper quadrant, and the liver span is normal. A liver biopsy is obtained, and microscopic examination shows bile duct proliferation and intracanalicular bile stasis, but no inflammation or hepatocyte necrosis. The level of which of the following is most likely to be increased in the patient's serum?
Which of the following is NOT a true statement about gallstones?
Sump syndrome occurs most commonly after which surgical procedure?
According to the Bismuth/Strasberg classification system, what type is cystic blow out?
What is the most common causative organism for ascending cholangitis?
What is the most common site of gallstone impaction?
Gallbladder adenocarcinoma is limited to the lamina propria. What is the preferred treatment?
Which of the following conditions of the gallbladder is precancerous?
Explanation: **Explanation:** **Acalculous cholecystitis** refers to acute inflammation of the gallbladder in the absence of gallstones. It typically occurs in critically ill patients due to a combination of **bile stasis** and **gallbladder ischemia**. **Why Estrogen Therapy is the Correct Answer:** Estrogen therapy (including oral contraceptives) is a well-known risk factor for **calculous** (stone-forming) cholecystitis. Estrogen increases the biliary excretion of cholesterol, leading to supersaturation of bile and the formation of cholesterol stones. It does not typically cause the ischemic or stasis-driven pathology seen in acalculous cases. **Analysis of Incorrect Options:** * **Diabetes Mellitus:** DM is a significant risk factor for acalculous cholecystitis due to associated autonomic neuropathy (leading to gallbladder stasis) and microangiopathy (leading to ischemia). * **Total Parenteral Nutrition (TPN):** TPN is a classic cause. The lack of enteral feeding results in a lack of Cholecystokinin (CCK) release, leading to gallbladder atony, profound bile stasis, and sludge formation. * **Leptospirosis:** This is a recognized infectious cause of acalculous cholecystitis, particularly in the pediatric population or as part of systemic vasculitis/multisystem involvement. **High-Yield Clinical Pearls for NEET-PG:** * **Most common setting:** Post-operative (major non-biliary surgery), severe trauma, burns, and prolonged ICU stay. * **Pathogenesis:** Ischemia (due to dehydration/shock) + Stasis (due to fasting/opioids). * **Diagnosis:** Ultrasound is the initial investigation (look for gallbladder wall thickening >4mm, pericholecystic fluid, and a positive **sonographic Murphy’s sign** in the absence of stones). **HIDA scan** is the most sensitive imaging modality (non-visualization of the gallbladder). * **Management:** Cholecystostomy (percutaneous drainage) is often preferred in unstable/critically ill patients; cholecystectomy is definitive.
Explanation: **Explanation:** Hydatid cyst of the liver, caused by the larval stage of **Echinococcus granulosus**, is a significant surgical topic for NEET-PG. **Why Option D is the Correct Answer:** While medical management (Albendazole) and percutaneous techniques (PAIR) exist, **surgery remains the definitive "gold standard" treatment**, especially for large, complicated, or superficial cysts at risk of rupture. In the context of this specific question format, surgery is emphasized as the primary curative modality to remove the endocyst and manage the residual cavity. **Analysis of Incorrect Options:** * **Option A:** While *E. granulosus* is the most common cause, this is a "fact" rather than the "most true" clinical management point in many surgical contexts (though in many standard textbooks, A is also considered true; however, if D is marked correct, the examiner is emphasizing the definitive management). * **Option B:** In approximately **70-75%** of cases, the cyst is single, but it is most commonly found in the **right lobe** of the liver. The 80% figure is slightly inaccurate compared to standard surgical texts (Bailey & Love). * **Option C:** Blood culture is **useless** for diagnosis as it is a parasitic infestation, not a bacterial infection. Diagnosis is primarily via **USG (Gharbi Classification)**, CT scan, and serology (ELISA for IgG antibodies). **Clinical Pearls for NEET-PG:** * **Pathognomonic Sign:** "Water lily sign" (detached germinal membrane) or "Floating membrane" on USG/CT. * **Casoni’s Test:** Now largely obsolete due to low sensitivity; replaced by ELISA. * **Scolicidal Agents:** Used during surgery to prevent peritoneal seeding. Common agents include **Hypertonic saline (20%)**, Cetrimide, or Silver nitrate. *Avoid Formalin due to risk of sclerosing cholangitis.* * **PAIR Criteria:** Indicated for Type I and II cysts; contraindicated for superficial cysts or those communicating with the biliary tree.
Explanation: ### Explanation The clinical presentation and biopsy findings point toward **Extrahepatic Biliary Obstruction (Obstructive Jaundice)**. **1. Why Alkaline Phosphatase (ALP) is Correct:** The patient presents with jaundice, colicky abdominal pain (suggestive of gallstones), and a high BMI. The liver biopsy shows **bile duct proliferation and intracanalicular bile stasis** without inflammation or necrosis—classic histological markers of mechanical obstruction. In response to bile duct pressure and the detergent action of bile salts, the biliary canalicular membranes synthesize increased amounts of **Alkaline Phosphatase**, which then leaks into the serum. This is the hallmark biochemical marker for cholestasis. **2. Why the Other Options are Incorrect:** * **Ammonia:** Elevated in end-stage liver disease or urea cycle defects where the liver fails to detoxify nitrogenous waste. This patient has no signs of cirrhosis or liver failure (normal liver span, no necrosis). * **Antimitochondrial Antibody (AMA):** This is the marker for **Primary Biliary Cholangitis (PBC)**. While PBC causes cholestasis, the biopsy would show "florid duct lesions" (granulomatous inflammation) and destruction of small ducts, not the simple proliferation and stasis seen here. * **Hepatitis C Antibody:** This would indicate viral hepatitis. Hepatitis typically presents with significant **hepatocyte necrosis and inflammation** on biopsy, which are explicitly absent in this case. **3. NEET-PG High-Yield Pearls:** * **Biopsy in Obstruction:** Bile duct proliferation is a compensatory response to pressure; "bile lakes" are pathognomonic for prolonged extrahepatic obstruction. * **ALP vs. GGT:** Both rise in cholestasis. If ALP is high but GGT is normal, consider bone disease. If both are high, the source is hepatobiliary. * **Courvoisier’s Law:** In a patient with jaundice, a palpable gallbladder is usually due to malignancy (e.g., head of pancreas) rather than stones, as stones cause a fibrotic, non-distensible gallbladder.
Explanation: **Explanation:** The correct answer is **D**. Gallstones are significantly more common in **females** than in males, typically following the classic "4 F's" rule: **Fat, Female, Fertile, and Forty**. Estrogen increases cholesterol secretion into bile, while progesterone leads to gallbladder stasis, both of which promote stone formation. Therefore, the statement that they are more common in males is incorrect. **Analysis of other options:** * **A. Lithogenic bile:** This is a prerequisite for cholesterol stone formation. It occurs when there is an imbalance in the bile composition—specifically, an excess of cholesterol relative to bile salts and phospholipids (supersaturation), leading to crystal nucleation. * **B. Carcinoma of the gallbladder:** There is a strong epidemiological link between long-standing cholelithiasis and gallbladder cancer. Large stones (>3 cm) and "porcelain gallbladder" (calcified wall) significantly increase the risk of malignancy. * **C. Diabetes Mellitus:** Diabetic patients have a higher prevalence of gallstones due to autonomic neuropathy causing gallbladder dysmotility (stasis) and altered lipid metabolism (increased biliary cholesterol). **High-Yield Clinical Pearls for NEET-PG:** * **Types of Stones:** Cholesterol stones (most common in West), Pigment stones (Black: hemolysis/cirrhosis; Brown: infection/biliary stasis). * **Investigation of Choice:** Transabdominal Ultrasonography (USG) is the gold standard (95% sensitivity). * **Asymptomatic Stones:** Generally do not require surgery unless the patient is a child, has a porcelain gallbladder, or stones are >3 cm. * **Saint’s Triad:** Gallstones, Hiatus hernia, and Diverticulosis.
Explanation: **Explanation:** **Sump Syndrome** is a late complication specifically associated with **Choledochoduodenostomy (Option B)**. In this procedure, the common bile duct (CBD) is anastomosed side-to-side with the duodenum. This creates a "sump" or a stagnant segment in the distal part of the CBD between the anastomosis and the Ampulla of Vater. Debris, stagnant bile, and food particles can accumulate in this distal limb, leading to bacterial overgrowth, stone formation, and recurrent cholangitis or pancreatitis. This anatomical configuration is unique to the side-to-side choledochoduodenostomy, making it the correct answer. **Analysis of Incorrect Options:** * **Cholecystojejunostomy (Option A):** This is a palliative bypass between the gallbladder and jejunum. While it can lead to cholecystitis if the cystic duct is obstructed, it does not create the specific distal CBD "sump" seen in Sump Syndrome. * **Mirizzi’s Syndrome (Option C):** This is a clinical condition where a stone impacted in the cystic duct or gallbladder neck causes extrinsic compression of the common hepatic duct. It is a pathology, not a surgical procedure. * **Choledochojejunostomy (Option D):** Usually performed as an end-to-side Roux-en-Y anastomosis. Because the distal CBD is typically ligated or the flow is diverted more physiologically, the stagnant "sump" effect is significantly less common than in side-to-side duodenal bypass. **High-Yield Pearls for NEET-PG:** * **Clinical Presentation:** Recurrent right upper quadrant pain, jaundice, and fever (Charcot’s triad) following a history of biliary bypass. * **Diagnosis:** ERCP is the gold standard as it is both diagnostic (showing filling defects in the distal CBD) and therapeutic. * **Management:** Endoscopic sphincterotomy is the treatment of choice to allow the "sump" to drain freely into the duodenum.
Explanation: The **Strasberg classification** (an expansion of the Bismuth classification) is the gold standard for describing laparoscopic bile duct injuries. Understanding the specific anatomical site of the leak or obstruction is crucial for NEET-PG. ### **Explanation of the Correct Answer** **Type A** injuries refer to minor bile leaks from the **cystic duct stump** or small ducts in the liver bed (Ducts of Luschka). A **"cystic blowout"** occurs when the clips on the cystic duct stump slip or fail, leading to a localized or generalized biliary collection. Since this involves the cystic duct specifically, it is categorized as Type A. ### **Analysis of Incorrect Options** * **Type B:** Involves the **occlusion** (clipping or ligation) of an aberrant right sectoral hepatic duct. There is no leak, but a segment of the liver is obstructed. * **Type C:** Involves the **transection** (cutting) of an aberrant right sectoral hepatic duct. Unlike Type B, this results in a continuous bile leak from the duct that is no longer connected to the common hepatic duct. * **Type D:** Refers to a **lateral injury** (partial tear) of the main bile duct (CBD or CHD) without complete loss of continuity. ### **Clinical Pearls for NEET-PG** * **Most Common Injury:** Type A is the most frequent biliary complication post-laparoscopic cholecystectomy. * **Bismuth Classification (Types 1-5):** Focuses primarily on major ductal injuries based on the distance from the hilar confluence (Type 1 is >2cm from confluence; Type 4 involves the confluence itself). * **Management:** Type A injuries are typically managed non-surgically via **ERCP with stenting** to decrease intraductal pressure, allowing the cystic stump to heal.
Explanation: **Explanation:** Ascending cholangitis is a clinical syndrome characterized by inflammation of the bile ducts, typically resulting from a combination of **biliary obstruction** (most commonly due to gallstones) and **bacterial infection** of the stagnant bile. **Why E. coli is the correct answer:** The biliary tract is normally sterile. However, when obstruction occurs, bacteria migrate retrograde from the duodenum into the biliary tree. **Escherichia coli** is the most frequently isolated pathogen in bile cultures (found in approximately 25–50% of cases), followed by *Klebsiella* and *Enterococcus*. As a Gram-negative aerobe normally resident in the gastrointestinal tract, it is the primary driver of the systemic inflammatory response seen in this condition. **Analysis of Incorrect Options:** * **Streptococcus (A):** While some *Enterococci* (formerly classified under Group D Streptococcus) are common, *Streptococcus* species themselves are less frequent primary isolates compared to Gram-negative coliforms. * **Proteus (B):** *Proteus* species can cause biliary infections but are significantly less common than *E. coli* and *Klebsiella*. * **Anaerobes (D):** Anaerobes (like *Bacteroides fragilis*) are often present in polymicrobial infections, especially in patients with previous biliary-enteric anastomoses, but they are rarely the sole or most common causative organism. **Clinical Pearls for NEET-PG:** * **Charcot’s Triad:** Fever, Jaundice, and Right Upper Quadrant (RUQ) pain. * **Reynold’s Pentad:** Charcot’s Triad + Hypotension and Altered Mental Status (indicates obstructive suppurative cholangitis). * **Management:** The priority is **biliary decompression** (usually via ERCP) and intravenous antibiotics. * **Most common Gram-positive isolate:** *Enterococcus*. * **Most common Gram-negative isolate:** *E. coli*.
Explanation: **Explanation:** The question refers to the pathophysiology of **Gallstone Ileus**, a mechanical bowel obstruction caused by a large gallstone (usually >2.5 cm) entering the bowel through a cholecystoenteric fistula (most commonly cholecystoduodenal). **Why Option B is Correct:** The **terminal ileum** is the narrowest part of the small intestine and possesses relatively weaker peristaltic activity compared to the proximal segments. Consequently, the most common site for a gallstone to become impacted is the **ileum, specifically 60–70 cm proximal to the ileocecal valve**. This is where the lumen diameter is at its minimum before entering the cecum. **Analysis of Incorrect Options:** * **Option A (Duodenojejunal junction):** While the stone enters the duodenum first, the lumen here is wide enough to allow passage. Impaction in the duodenum is rare and leads to **Bouveret Syndrome** (gastric outlet obstruction). * **Option C (Distal to the ileocecal junction):** Once a stone passes the ileocecal valve, it enters the colon, which has a much larger diameter, making impaction distal to the valve highly unlikely. * **Option D (Colon):** Impaction in the colon is rare and usually only occurs if there is a pre-existing stricture (e.g., diverticulitis or malignancy). **High-Yield Clinical Pearls for NEET-PG:** * **Rigler’s Triad (X-ray findings):** 1. Pneumobilia (air in the biliary tree), 2. Small bowel obstruction, 3. Ectopic radiopaque gallstone. * **Most common fistula:** Cholecystoduodenal fistula. * **Treatment:** Enterolithotomy (extraction of the stone via a proximal enterotomy). The gallbladder is usually addressed in a delayed setting. * **Demographics:** Typically seen in elderly females with a history of chronic cholecystitis.
Explanation: **Explanation:** The management of gallbladder adenocarcinoma is primarily determined by the **T-stage** (depth of invasion). **1. Why Simple Cholecystectomy is Correct:** According to the TNM staging, a tumor limited to the lamina propria is classified as **T1a**. For T1a lesions, a simple cholecystectomy is considered curative, with 5-year survival rates exceeding 95-100%. At this early stage, the risk of lymph node metastasis is negligible (less than 2.5%), making extensive radical surgery unnecessary. **2. Why Incorrect Options are Wrong:** * **Radical Cholecystectomy (Option B):** This involves cholecystectomy plus wedge resection of the liver (Segments IVb and V) and regional lymphadenectomy. It is the treatment of choice for **T1b** (invasion into the muscularis) and **T2** tumors. Performing it for T1a provides no survival benefit and increases morbidity. * **Chemotherapy (Option C) & Radiotherapy (Option D):** These are typically used as adjuvant treatments for advanced stages or as palliative measures for unresectable disease. They are not primary treatments for early-stage (T1a) localized gallbladder cancer. **Clinical Pearls for NEET-PG:** * **Incidental Finding:** Most T1a gallbladder cancers are discovered incidentally during histopathological examination after a routine cholecystectomy for gallstones. * **T1a vs. T1b:** This is a high-yield distinction. **T1a** (lamina propria) = Simple Cholecystectomy; **T1b** (muscularis) = Radical Cholecystectomy. * **Nevin’s Staging:** Stage I corresponds to intramucosal involvement, similar to T1a. * **Port-site recurrence:** If gallbladder cancer is suspected or confirmed, avoid using a retrieval bag or spilling bile to prevent port-site metastasis.
Explanation: **Explanation:** **Porcelain Gallbladder (Option B)** is the correct answer. It refers to the intramural calcification of the gallbladder wall, often resulting from chronic cholecystitis. Historically, it was associated with a very high risk of gallbladder carcinoma (up to 25%). While recent studies suggest a lower risk (approx. 7%), it remains a definitive **precancerous condition**, and prophylactic cholecystectomy is generally recommended even in asymptomatic patients. **Analysis of Incorrect Options:** * **Cholesterosis (Option A):** Also known as "Strawberry Gallbladder," this involves the deposition of cholesterol esters in the lamina propria. It is a benign metabolic condition and carries **no malignant potential**. * **Biliary Atresia (Option C):** This is a neonatal obstructive jaundice condition caused by the destruction of the extrahepatic biliary tree. While it leads to secondary biliary cirrhosis and may increase the risk of **cholangiocarcinoma** or **hepatocellular carcinoma** later in life, it is not a primary precancerous condition of the gallbladder itself. * **Choledochal Cyst (Option D):** While this is a significant precancerous condition, it primarily predisposes to **cholangiocarcinoma** (cancer of the bile ducts), not gallbladder cancer specifically (though Type IV and V cysts have high risks). **High-Yield Clinical Pearls for NEET-PG:** * **Gallbladder Carcinoma Risk Factors:** Porcelain GB, gallstones >3cm, gallbladder polyps >10mm, and anomalous pancreaticobiliary duct junction (APBDJ). * **Radiology:** Porcelain GB is characterized by a "curvilinear rim of calcification" in the gallbladder fossa on a plain X-ray or CT. * **Management:** Prophylactic cholecystectomy is the treatment of choice for Porcelain GB due to the risk of malignancy.
Liver Anatomy and Physiology
Practice Questions
Benign Liver Lesions
Practice Questions
Liver Abscess
Practice Questions
Hepatocellular Carcinoma
Practice Questions
Metastatic Liver Disease
Practice Questions
Cirrhosis and Portal Hypertension
Practice Questions
Liver Trauma
Practice Questions
Cholelithiasis and Cholecystitis
Practice Questions
Choledocholithiasis
Practice Questions
Biliary Tract Tumors
Practice Questions
ERCP and Its Complications
Practice Questions
Liver Transplantation Basics
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free